These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

185 related items for PubMed ID: 2476608

  • 1. Long-term double-blind comparison of doxazosin and atenolol in patients with mild to moderate hypertension.
    Lijnen P, Fagard R, Staessen J, Lissens W, Amery A.
    J Cardiovasc Pharmacol; 1989 Aug; 14(2):319-25. PubMed ID: 2476608
    [Abstract] [Full Text] [Related]

  • 2. Antihypertensive effect of doxazosin and atenolol in short- and long-term double-blind comparison.
    Lijnen P, Fagard R, Staessen J, Amery A.
    Methods Find Exp Clin Pharmacol; 1990 Oct; 12(8):563-73. PubMed ID: 2151197
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Comparison of the effects of doxazosin and atenolol on blood pressure and blood lipids: a one-year, double-blind study in 228 hypertensive patients.
    Talseth T, Westlie L, Daae L, Vatle S.
    Am Heart J; 1988 Dec; 116(6 Pt 2):1790-6. PubMed ID: 2904752
    [Abstract] [Full Text] [Related]

  • 7. Multicenter, double-blind comparison of doxazosin and atenolol in patients with mild to moderate hypertension.
    Ott P, Storm TL, Krusell LR, Jensen H, Badskjaer J, Faergeman O.
    Am J Cardiol; 1987 May 29; 59(14):73G-77G. PubMed ID: 2884856
    [Abstract] [Full Text] [Related]

  • 8. Serum lipid changes in a one-year, multicenter, double-blind comparison of doxazosin and atenolol for mild to moderate essential hypertension.
    Frick MH, Cox DA, Himanen P, Huttunen M, Pitkäjärvi T, Pörsti P, Pöyhönen L, Pyykönen ML, Reinikainen P, Salmela P.
    Am J Cardiol; 1987 May 29; 59(14):61G-67G. PubMed ID: 2884854
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Doxazosin versus atenolol: a randomized comparison of calculated coronary heart disease risk reduction.
    Mazzola C, Guerrasio E.
    Am Heart J; 1988 Dec 29; 116(6 Pt 2):1797-801. PubMed ID: 2904753
    [Abstract] [Full Text] [Related]

  • 12. Double-blind comparison of the effects of long-term treatment with doxazosin or atenolol on serum lipoproteins.
    Lehtonen A, Himanen P, Saraste M, Niittymäki K, Marniemi J.
    Br J Clin Pharmacol; 1986 Dec 29; 21 Suppl 1(Suppl 1):77S-81S. PubMed ID: 2939871
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. A long-term study of atenolol and doxazosin in mild and moderate hypertension.
    Talseth T, Westlie L, Daae L.
    J Hum Hypertens; 1990 Oct 29; 4 Suppl 3():39-44. PubMed ID: 2148194
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Comparative effects of doxazosin and hydrochlorothiazide on serum lipids and blood pressure in essential hypertension.
    Trost BN, Weidmann P, Riesen W, Claessens J, Streulens Y, Nelemans F.
    Am J Cardiol; 1987 May 29; 59(14):99G-104G. PubMed ID: 2884861
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.